Vericel Corp Valuation
| VCEL Stock | USD 36.82 0.86 2.39% |
At this time, the company appears to be undervalued. Vericel Corp Ord has a current Real Value of $46.32 per share. The regular price of the company is $36.82. Our model measures the value of Vericel Corp Ord from inspecting the company fundamentals such as Shares Outstanding of 50.57 M, return on equity of 0.0452, and Operating Margin of 0.05 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Vericel Corp's valuation include:
Price Book 5.652 | Enterprise Value | Enterprise Value Ebitda 74.9117 | Price Sales 7.0295 | Forward PE 48.5437 |
Undervalued
Today
Please note that Vericel Corp's price fluctuation is very steady at this time. Calculation of the real value of Vericel Corp Ord is based on 3 months time horizon. Increasing Vericel Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Vericel stock is determined by what a typical buyer is willing to pay for full or partial control of Vericel Corp Ord. Since Vericel Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vericel Stock. However, Vericel Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 36.82 | Real 46.32 | Target 55.0 | Hype 37.01 |
The intrinsic value of Vericel Corp's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Vericel Corp's stock price.
Estimating the potential upside or downside of Vericel Corp Ord helps investors to forecast how Vericel stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vericel Corp more accurately as focusing exclusively on Vericel Corp's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Vericel Corp's intrinsic value based on its ongoing forecasts of Vericel Corp's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Vericel Corp's closest peers.
Vericel Corp Cash |
|
Vericel Corp Total Value Analysis
Vericel Corp Ord is at this time forecasted to have valuation of 1.78 B with market capitalization of 1.82 B, debt of 98.85 M, and cash on hands of 100.69 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Vericel Corp fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.78 B | 1.82 B | 98.85 M | 100.69 M |
Vericel Corp Investor Information
About 99.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 357.33. Vericel Corp Ord had not issued any dividends in recent years. The entity had 1:20 split on the 16th of October 2013. Based on the analysis of Vericel Corp's profitability, liquidity, and operating efficiency, Vericel Corp Ord is doing better financially today then in previous quarter. It has a moderate odds of reporting better financial numbers in March.Vericel Corp Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Vericel Corp has an asset utilization ratio of 54.82 percent. This suggests that the Company is making $0.55 for each dollar of assets. An increasing asset utilization means that Vericel Corp Ord is more efficient with each dollar of assets it utilizes for everyday operations.Vericel Corp Profitability Analysis
Considering Vericel Corp's profitability and operating efficiency indicators, Vericel Corp Ord is performing exceptionally good at this time. It has a great odds to showcase excellent profitability results in March. Profitability indicators assess Vericel Corp's ability to earn profits and add value for shareholders.Net Income | First Reported 1996-09-30 | Previous Quarter -553 K | Current Value 5.1 M | Quarterly Volatility 4.6 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.79 | 0.83 |
|
|
For Vericel Corp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vericel Corp Ord to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vericel Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vericel Corp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vericel Corp over time as well as its relative position and ranking within its peers.
Vericel Corp Earnings per Share Projection vs Actual
The next projected EPS of Vericel Corp is estimated to be -0.075 with future projections ranging from a low of -0.17 to a high of 0.11. Vericel Corp's most recent 12-month trailing earnings per share (EPS TTM) is at 0.26. Please be aware that the consensus of earnings estimates for Vericel Corp Ord is based on EPS before non-recurring items and includes expenses related to employee stock options.Vericel Corp Earnings Estimation Breakdown
The calculation of Vericel Corp's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Vericel Corp is estimated to be -0.075 with the future projection ranging from a low of -0.17 to a high of 0.11. Please be aware that this consensus of annual earnings estimates for Vericel Corp Ord is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.17 Lowest | Expected EPS | 0.11 Highest |
Vericel Corp Earnings Projection Consensus
Suppose the current estimates of Vericel Corp's value are higher than the current market price of the Vericel Corp stock. In this case, investors may conclude that Vericel Corp is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Vericel Corp's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 8 | 38.06% | 0.0 | -0.075 | 0.26 |
Vericel Corp Ownership Allocation
The majority of Vericel Corp Ord outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Vericel Corp to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Vericel Corp Ord. Please pay attention to any change in the institutional holdings of Vericel Corp Ord as this could imply that something significant has changed or is about to change at the company.Vericel Corp Profitability Analysis
The company reported the previous year's revenue of 237.22 M. Net Income was 10.36 M with profit before overhead, payroll, taxes, and interest of 190.97 M.About Vericel Corp Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Vericel Corp Ord. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Vericel Corp Ord based exclusively on its fundamental and basic technical indicators. By analyzing Vericel Corp's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Vericel Corp's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vericel Corp. We calculate exposure to Vericel Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vericel Corp's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 197.9 M | 207.8 M | |
| Pretax Profit Margin | 0.05 | 0.05 | |
| Operating Profit Margin | 0.02 | 0.02 | |
| Net Profit Margin | 0.05 | 0.05 | |
| Gross Profit Margin | 0.83 | 0.79 |
Vericel Corp Growth Indicators
Investing in growth stocks can be very risky. If the company such as Vericel Corp does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 51.7 M | |
| Quarterly Earnings Growth Y O Y | 0.476 | |
| Forward Price Earnings | 48.5437 |
Vericel Corp Current Valuation Indicators
Vericel Corp's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Vericel Corp's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Vericel Corp, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Vericel Corp's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Vericel Corp's worth.When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Vericel Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.476 | Earnings Share 0.26 | Revenue Per Share | Quarterly Revenue Growth 0.166 | Return On Assets |
Investors evaluate Vericel Corp Ord using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Vericel Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Vericel Corp's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Vericel Corp's market price signifies the transaction level at which participants voluntarily complete trades.